Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 43Gynecologic 20Dermatologic 9Head & Neck 7Gastrointestinal 5Tumor-Agnostic 2Other hematologic neoplasm 2Lymphoid 2Genitourinary 2Thoracic 1Sarcoma 1Other solid neoplasm 1

Conditions

Pediatric Patients With Solid Tumors 1

Interventions

Cisplatin 145pembrolizumab 129Carboplatin 125Injections 108Pemetrexed 97Paclitaxel 97Gemcitabine 85Irinotecan 75Nivolumab 71Cyclophosphamide 71Docetaxel 68Bevacizumab 57Oxaliplatin 49Fluorouracil 48atezolizumab 46Capecitabine 46Etoposide 42Leucovorin 41tislelizumab 40toripalimab 36fludarabine 32Ipilimumab 30Drug Therapy 30Topotecan 29durvalumab 28Vincristine 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26Specimen Handling 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sentinel Lymph Node Biopsy × Other solid neoplasm × Clear all
NCT02910726 2022-10-05

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

Memorial Sloan Kettering Cancer Center

Phase 2/3 Completed
6 enrolled 4 charts
Other solid neoplasm

Pediatric Patients With Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡